Nicholas Piramal India Limited (NPIL), one of India’s leading pharmaceutical companies, today launched a revolutionary product, ‘RESPeRATE’, aimed at the management of hypertension. RESPeRATE is a patented product, developed on the yogic principles of Pranayama. It is the first and only medical device cleared by the US FDA for adjunctive treatment of hypertension.

RESPeRATE is a portable electronic device that helps lower blood pressure naturally by enabling the patient to quickly harness the power of paced breathing. Scientific evidence has shown that paced breathing, if done effortlessly, can lower blood pressure significantly by relaxing the muscles surrounding constricted blood vessels. It is the only medical device for high blood pressure treatment using patented Interactive Respiratory Pacing technology.

Benefits offered by RESPeRATE:

· A proven, effective, non-drug approach to lowering high blood pressure

· 14/8 mm Hg average BP reduction within 8 weeks

· No side effects, no drug interactions, pleasant to use

· Well supported with clinical trials

RESPeRATE is available in India directly from Nicholas Piramal India Ltd., (contact – 022-30466543, [email protected])

Speaking at the launch, Dr. Swati Piramal, Director – Strategic Alliances & Communications, NPIL, said, “RESPeRATE is a perfect fit within our health solutions portfolio. It complements well our existing pharmacy product offerings, and we look forward to bringing our expertise to this innovative solution for hypertension in India. Considerable effort is needed to prevent and reduce the increasingly large burden of hypertension in India.”

“This is great news for the millions of hypertension sufferers in India who seek a new option to help control their condition. Traditional treatment methods of diet, exercise and medication are often unable to help patients reach their lower blood pressure goals. Left untreated, high blood pressure may lead to heart attack, stroke and kidney or heart failure,” said Dr. Hiremath, HoD, Department of Cardiology, Poona Hospital & Research Center.

RESPeRATE is manufactured by Intercure Ltd. – an Israeli company founded in 1997 that is headquartered in Fort Lee, New Jersey.

Sourced From: The PRactice

Tags: calls, daytrading, free calls, intraday, tips

Similar Posts:

• Nicholas Piramal reports revenues grow 13% to Rs 7.3bn
• Siemens launches SOMATOM Definition AS+
• Piramal Life Sciences to invest Rs 200 cr in R&D
• Glaxo in talks to buy Piramal Healthcare: report
• Buy Piramal Healthcare, target of Rs 358: Sharekhan